Medical secretary: Adam Ovid
Tel: 020 7188 7188 (ext 56079)
Email: email@example.com and firstname.lastname@example.org
Area of expertise: thoracic oncology (including lung cancer): trials
Professor of Experimental Cancer Medicine, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Hospitals London, UK.
Dr Spicer is Professor of Experimental Cancer Medicine at King’s College London, and Consultant in Medical Oncology at Guy’s and St Thomas’ Hospitals. He runs the King’s Health Partners Cancer Early Phase Trials programme. He is joint lead of the King’s Experimental Cancer Medicine Centre, funded by Cancer Research UK/National Institute for Health Research. Dr Spicer’s interests include the care of patients with thoracic malignancies, including lung cancer and mesothelioma, and clinical trials in these diseases. His translational research focus is on novel treatment including immunotherapies.
He is a member of CRUK’s New Agents Committee and other UK national funding panels.
- FCRP (London), 2012
- PhD (ICR, University of London), 2002
- MRCP (London), 1998
- MB, BS (Guy’s and St Thomas’, University of London), 1995
- BA Biochemistry (Christ Church, University of Oxford), 1987
- 2004 - McElwain Prize from the Association of Cancer Physicians
- 1998 - Clinical Research Fellowship, Institute of Cancer Research
Clinical interests include the care of patients with thoracic malignancies, including lung cancer and mesothelioma, clinical trials in these diseases, and Phase 1 trials in all solid tumours.